Amber List

CRSPCRISPR Therapeutics AG

Healthcare · Biotechnology · mid-cap ($4.7B)
-34.4%
from rolling 252-day high of $75.06 set 2025-10-21 · 360d ago
Current
$49.25
Decline depth
-34.4%
Decline σ
5.9σ
TFC
4/5 bearish

Where it stands

On the Amber List.

Down 34.4% from its rolling 252-day high, 360 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Amber List; recovery signal active → Amber List.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

CRSP qualifies for the Amber List on decline depth.

Down 34.4% from its rolling 252-day high, 360 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-34.4%
From rolling 252-day high of $75.06, 360d ago. Past the 30% Amber threshold.
Time-frame continuity
4/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3. Past the 4/5 Amber threshold.
Decline sigma
5.9σ
Drop over the last 20 bars in units of daily volatility (3.27%/day). Past the ≥4σ Watch threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Amber List; recovery signal active → Amber List
  2. Amber List → Amber List; recovery signal active
  3. Amber List; recovery signal active → Amber List
  4. Amber List → Amber List; recovery signal active
  5. Amber List; recovery signal active → Amber List
  6. Amber List → Amber List; recovery signal active
  7. Amber List; recovery signal active → Amber List
  8. Amber List → Amber List; recovery signal active
  9. Amber List; recovery signal active → Amber List
  10. Amber List → Amber List; recovery signal active
  11. Amber List; recovery signal active → Amber List
  12. Red List; recovery signal active → Amber List; recovery signal active

Showing the latest 12 of 35 recorded events.

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about CRSP.

CRSP qualifies for the Amber List on decline depth — down -34.4% from its rolling 252-day high.

Cross-confirmation: also showing 4/5 bearish time frames.

Cross-confirmation: decline sigma also reads 5.9σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 2D (red).

Questions about CRSP

What people ask.

Why is CRSP on Broken Stocks?

CRSP qualifies for the Amber List on decline depth. It is down -34.4% from its rolling 252-day high of $75.06, set on 2025-10-21 — 360d ago.

Is CRSP a falling knife?

Not by the strict technical definition. CRSP is down -34.4% from its 52-week high, but that high was set 360d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CRSP is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is CRSP a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CRSP trading inside its 52-week range?

At $49.25, CRSP sits 14.9% of the way from its 52-week low ($44.12) to its 52-week high ($78.48). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CRSP been declining?

The current 34.4% decline accrued over 360d, which annualizes to roughly -34.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CRSP compare to its sector?

There are 408 other Healthcare tickers on Broken Stocks: 274 Red, 94 Amber, 40 Watch, with 178 showing recovering structural signals. Median sector decline is -37.5% — CRSP's decline is shallower than the sector median.